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ABSTRACT 
Objective: To describe the visual outcome following phacoemulsification in English Cocker 
Spaniels (ECS) affected by cataracts and suspected progressive retinal atrophy (PRA).  
Animals studied: 54 client-owned dogs. 
Procedures: A multicentre, retrospective study was performed including ECS with suspected 
PRA which underwent phacoemulsification. PRA was suspected on ophthalmic examination 
before and after surgery, and/or after electroretinography (ERG) was performed. Visual 
outcome was assessed by menace response per eye at seven time periods post-surgery 
(P1=25-90 days, P2=91-180 days, P3=181-364 days, P4=365-549 days, P5=550-729 days, 
P6=730-1094 days, P71095 days). Descriptive statistics were performed. Generalized 
estimating equations were used to identify predictors associated with vision after surgery. 
Odds ratio and confidence intervals were reported. Significance was set at p<0.05. Owners 
were invited to participate in a questionnaire. 
Results: Phacoemulsification was performed in 85 eyes. Median age at surgery was 9.09 
years (min. 2.17 years, max. 13.49 years). At all re-examinations, up to and including P5, 
significantly more eyes were visual than before surgery (p0.003). Odds for vision were 
significantly increased for eyes that underwent surgery.  Electroretinograms were performed 
in 75/85 eyes that underwent surgery, demonstrating low b-wave amplitudes. There was no 
significant effect of the age, gender, vision before surgery, presence of dazzle reflex, cataract 
stage or abnormality on gonioscopy on visual outcome. The questionnaire response rate was 
48.2%. Most participants (92.5%) felt that cataract surgery led to improvement of the dog’s 
quality of life.  
Conclusions: English Cocker Spaniels with suspected PRA may benefit from 
phacoemulsification with vision up to two years following surgery. 
Key words: PRA, progressive retinal atrophy, cataract, phacoemulsification 
Introduction 
Cataracts are a common cause of blindness in dogs. Possible causes of cataract include 
inherited, congenital, aging, progressive retinal atrophy (PRA) and diabetes mellitus.(1-8) As 
the cataract progresses, secondary complications such as lens-induced uveitis and secondary 
glaucoma can develop, which may cause ocular discomfort or pain.(1-3) Surgical removal of 
the cataract holds the best prognosis for restoring vision and improving the overall ocular 
health, compared to medical management only or no treatment at all.(3) Surgical success 
rates of 85-90 % have been reported. (4-6) Long-term complications after 
phacoemulsification include posterior capsular opacification, corneal lipid opacity, 
intraocular haemorrhage, glaucoma and retinal detachment, which may lead to blindness or 
enucleation. (4,6-9) 
Progressive retinal atrophy is a broad term for a variety of progressive, inherited diseases of 
the retina, that manifest as degeneration of the photoreceptor layer and/or the retinal 
pigmented epithelium in many different dog breeds.(10,11) It has been reported to be the 
third most common cause of cataracts accounting for 7.6 % and 12.5 % of cases in two 
retrospective studies.(12,13) Cataracts secondary to PRA have been described to develop at 
advanced stages of PRA in some breeds.(11,14) Historically, cataract surgery has not been 
recommended routinely in dogs affected by PRA, as these dogs will progressively lose vision 
despite the surgery.(15) Disease onset and progression, as well as the underlying genetic 
mutations causative of PRA, vary between and within breeds.(16-18) Many breeds are 
affected by a progressive rod-cone degeneration (prcd) with an identical mutation in the prcd 
locus, which is responsible for a late-onset form PRA.(17) Interestingly, phenotypic 
differences have also been reported between breeds affected by the same prcd mutation. The 
English Cocker Spaniel (ECS) demonstrated a slower rate of photoreceptor degeneration 
histologically, compared to the Miniature Poodle (MP) and American Cocker Spaniel 
(ACS).(17,19) Furthermore, ECS showed a mosaic of disease stages across the meridians of 
the fundus, with areas of delayed retinal degeneration. On ERG examination, MP’s lost their 
remaining b-wave function twice as fast as ECS.(19) Supported by these findings in the ECS, 
the frequent presentation of this breed with cataracts and anecdotal clinical experiences of 
late onset vision loss, the authors have performed cataract surgery in ECS following careful 
owner counselling.  
The main objective of this retrospective study was to describe the visual outcome at various 
re-examination periods following phacoemulsification in ECS with suspected PRA. The 
second objective was to investigate any predictors associated with a positive visual outcome 
following surgery.  
 
Materials and Methods  
A retrospective multicentre study was performed. Databases of the Royal Veterinary College 
(RVC), the Animal Health Trust (AHT) and Dick White Referrals (DWR) were searched for 
ECS with suspected progressive retinal atrophy and cataracts, which underwent 
phacoemulsification between 2002 and 2017. Ethical approval was obtained from the RVC 
Clinical Research Ethical Review Board (CRERB, URN: M2015 0073) and AHT Clinical 
Research Ethics Committee (41-2016). 
Dogs were included if they underwent a full ophthalmic examination including slit-lamp 
biomicroscopy, indirect binocular ophthalmoscopy and tonometry before and after surgery by 
a diplomate or a resident under the supervision of a diplomate of the European College of 
Veterinary Ophthalmologists (ECVO). Gonioscopy (Koeppe lens, Ocular instruments inc., 
Washington, USA) and ocular ultrasound results were reported from examinations before 
surgery. Furthermore, information about the presence of concurrent systemic disease or 
ocular diseases was collected.  
A diagnosis or suspicion of PRA was made based on the patient history, signalment, full 
ophthalmic examination before or after surgery and, in the majority of cases, supported by 
the ERG results. In all referral centres, a short ‘yes/no’ ERG protocol was employed to assess 
gross photoreceptor function. The protocols used among the centres varied. A summary of 
the ERG protocols used is demonstrated in table 1. ERGs were performed in conscious dogs 
at the AHT and at DWR and under general anaesthesia at the RVC. The ERG machines used 
were, HMsERG system (Model 2000 OcuScience, Henderson, NV) at the RVC and DWR, 
and Photic stimulator (SLE, CPS-20; Medilec Synergy, VIASYS, Madison, USA) at the 
AHT. Dogs with a b-wave amplitude below 40mV were included. The b-wave amplitude of 
the mixed/rod cone response was used at the RVC and the b-wave amplitude of a cone 
dominated ERG curve was assessed at the AHT and DWR. The cases with no ERG, but with 
suspected PRA, were included following careful selection based on their history, signalment, 
full ophthalmic examination, the presence of attenuated retinal vascularization and tapetal 
hyper-reflectivity on funduscopy and if visual deficits in low light were reported. ECS with 
uni-or bilateral phacoemulsification were evaluated.  
Visual outcome post-surgery was assessed in all ECS presented at re-examinations by 
ophthalmic examination, particularly the menace response, at seven time-periods post-
surgery (P1 = 25-90 days, P2 = 91-180 days, P3 = 181-364 days, P4 = 365-549 days, P5 = 
550-729 days, P6 = 730-1094 days, p7  1095 days). Other methods of visual assessment 
(obstacle/maze tests, tracking response and visual placing response) were also reported in a 
number of cases, but not consistently in all dogs. The results of genetic testing were reported 
if available.  
Owners were invited to participate in a simple questionnaire by email, letter or telephone call, 
asking: 
1) Is your pet still visual or how long has he/she been visual in your opinion?  
2) Do you feel that cataract surgery has improved your pet’s quality of life?  
 
Frequencies and percentages were reported for the categorical variables: gender, operated 
eye, menace response per eye, ERG, the presence of a flat trace and postoperative 
complications. The RVC databank RxWorks 5.2.4195 was searched to investigate the 
frequency of ECS presented to the RVC in general and to the ophthalmology department 
between 2002 and 2017. Medians (minimum, maximum) were reported for numerical 
variables like age and ERG b-wave amplitudes per eye. McNemar’s tests were performed to 
compare visual outcome before and after surgery. Generalized estimating equations (GEE) 
with binomial logit link function were used to assess association between age, gender, centre, 
presence of a dazzle reflex, cataract grade, abnormalities on gonioscopy or ocular ultrasound, 
presence of vision before surgery or a flat trace on ERG with the postoperative visual 
outcome. Odds ratio (OR) and 95% confidence intervals (CI) are presented for results of the 
generalized estimating equation. Statistical significance was set at p < 0.05. All analyses were 
performed with IBM SPSS Statistics (Version 24; IBM Corp., Armonk, NY, USA). Graphic 
illustrations were created with GraphPad Prism (Version 7.00 for Windows, GraphPad 
Software, La Jolla California USA) and R (Version 3.4.2, R Foundation for Statistical 
Computing, Vienna, Austria). 
 
Results: 
There were 54 ECS included in this study (RVC 14 cases, AHT 32 cases and DWR 8 cases), 
comprising 28 (51.9 %) males and 26 (48.1 %) females. Phacoemulsification was performed 
in 85 of 108 eyes, comprising 41 right eyes (48.2 %) and 44 left eyes (51.8 %). Bilateral 
phacoemulsification was performed in 31 dogs (57.4 %) and unilateral in 23 dogs (42.6 %). 
Seventy-three (85.9 %) intraocular lenses (IOL) were placed. Phacoemulsification was 
performed on separate days in 8/54 dogs (14.8 %) and on the same day in 46/54 dogs (85.2 
%). The median age at surgery was 9.09 years (Min. 2.17 years, Max. 13.49 years). 
The ECS was the fourth most common breed (4 % of the total population), presented to the 
RVC between 2002 and 2017 and the second most common breed (7 % of the total 
population) presented to the ophthalmology department of the RVC during the same time 
period. Funduscopy supported the suspicion of PRA in all operated eyes either before surgery 
(4/85, 4.7%) or at re-examinations (81/85, 95.3%) following surgery. Funduscopic details 
like tapetal hyperreflectivity (78/85, 91.8%), attenuated retinal vascularisation (67/85, 78.8%) 
and a pale or atrophied optic nerve head (11/85, 12.9%) were described in most patient 
records. Clinicians have used the general term progressive retinal atrophy to describe 
funduscopic findings in all cases.  
An ERG was performed in 75/85 (88.2 %) operated eyes. All ERGs were consistent with 
reduced retinal function and the median ERG b wave amplitude was 10mV (Min. 0mV, max 
40mV) in all eyes. A flat ERG trace was found in 30 (40 %) of the operated eyes. One dog 
was tested positive for the prcd gene mutation (Optigen, Ithaka, NY, USA). Ten eyes of eight 
patients did not undergo an ERG, all of which demonstrated tapetal hyperreflectivity, 
attenuated retinal vessels on funduscopy and all of these patients were nyctalopic.  
A concurrent diagnosis of diabetes mellitus was not reported in any dog. Eight dogs had been 
diagnosed with keratoconjunctivitis sicca (KCS, 14.8 %) at the time of the first examination. 
Cataracts were described as incipient (1/85, 1.2%), immature (40/85, 47.1%), mature (38, 
44.7%) and hypermature (6/85, 7.1%). The cataract stage was significantly associated with 
blindness before the surgery (p = 0.004). Following the surgery there was no association 
between previous cataract grade and visual outcome. There were statistically significant 
associations at P4 (p = 0.003) and P5 (p = 0.029). However, these were considered 
questionable, due to the loss to follow up, as there were only 1 and 3 blind patients that 
presented for each period. A higher number of re-examined patients would be required to 
avoid bias. Gonioscopy was performed in 27 (25%) of 108 eyes in total with 16 (59.2%) 
abnormal findings of the iridocorneal angle (ICA). There were descriptions of seven narrow 
ICAs (7/27, 25.9%), six eyes with narrow ICAs alongside pectinate ligament dysplasia (PLD) 
(6/27, 22.2%), three eyes with PLD only (3/27, 11.1%) and 11 normal findings (11/27, 
40.7%). An abnormal finding on gonioscopy did not affect the visual outcome of operated 
eyes in this study statistically and none of these cases developed glaucoma following surgery 
(p < 0.001). Ocular ultrasound was performed in 93 (86.1%) of 108 eyes and abnormalities 
were reported in 24 (22.2%) eyes. The most frequent finding was vitreal degeneration (n = 
22, 20.3%). There was a single case of lenticonus and one suspected persistent tunica 
vasculosa lentis, which was not confirmed following surgery. There were no cases of retinal 
detachment.  
 
Before surgery, 19 (22.4%) of the operated eyes demonstrated a positive menace response 
and 66 (77.6%) eyes had a negative response. However, significantly more eyes had a 
positive menace response post operatively from re-examination period P1 until and including 
P5 (p  0.003), compared to the menace response before surgery. See table2 / figure 1 and 
figure 2  
Thirty eyes (40 %) undergoing cataract surgery demonstrated a flat trace on ERG. Before 
surgery, five (16.7 %) of these eyes had a positive menace response and 25 eyes (83.3 %) had 
a negative menace response. Of the five eyes with flat trace readings and positive menace 
responses, two ERGs were measured consciously, three ERGs were measured under general 
anaesthesia. Despite the flat ERG traces in 30 eyes, there was significant improvement of 
vision from P1 to P4 (p  0.031). See table 3/figure 3  
There were increased odds for vision if an eye underwent phacoemulsification compared to 
eyes not undergoing surgery at P1 (p < 0.001, OR = 12.89, CI = 4.33, 38.8), P2 (p < 0.001, 
OR = 23.70, CI = 5.18, 108.39) and P3 (p < 0.001, OR = 157.55, CI = 17.34, 1431.43). The 
GEE could not be performed for P4, P5, P6 and P7 as there were zero visual eyes in the 
group that had not undergone surgery. Abnormalities on ocular ultrasound did not have any 
statistical effect on the presence of a flat line on ERG or on the visual outcome of operated 
eyes in this study. The presence of a dazzle reflex before surgery did not have a significant 
effect on vision post-surgery. The presence or absence of an IOL did not have an effect on 
the presence of vision statistically. There was no significant effect of referral centre, age, 
gender or vision before surgery on visual outcome.  
 
Of all 85 eyes operated, 39 (45.9%) presented with complications throughout the re-
examination time periods. Complications included KCS (n = 17, 20.0%, not including 
previously diagnosed patients), glaucoma (n = 11, 12.9%), corneal ulceration (n = 6, 7.1%), 
mineral or lipid deposits in the cornea (n = 3, 3.5%), corneal endothelial disease (n = 4, 
4.7%), endophthalmitis (n = 3, 3.5%) and intraocular artificial lens luxation (n = 1, 1.2%). 
Four eyes of three dogs were enucleated due to secondary glaucoma. One eye was removed 
at day one following surgery; however, glaucoma was present in this eye before surgery. Two 
eyes of the same dog (only the left eye was operated) were enucleated 2.5 years and one eye 
3.5 years following surgery. See figure 4 
Twenty-seven owners replied to the brief questionnaire (27/56, 48.2% reply rate). Most 
owners felt positive about the surgery and reported that the quality of life of their pet had 
improved (25/27 replies, 92.5%). The question for vision was not answered uniformly with 




Historically, due to the inevitable progressive loss of vision, reports that cataracts develop in 
the late stages of PRA and that phacoemulsification does not benefit patients with underlying 
PRA, surgery has not been recommended routinely.(11,14,15). The risks and complications 
of the surgery always need to be outweighed by the advantages, which could be improved 
vision and overall ocular health. Cataracts are not only an opacity leading to blindness, but 
may lead to lens-induced uveitis, lens luxation or glaucoma.(1-3,20) Therefore, in a study by 
Lim et al. it was discussed that phacoemulsification could be performed to decrease risks of 
ocular disease secondary to the cataracts. (3) In patients with PRA, it is expected that vision 
will be gradually lost, even after phacoemulsification of their secondary cataracts. However, 
there are breed-related differences in the onset and progression of PRA. It has been reported 
that ECS are affected by a relatively late onset and slowly progressive form of PRA, as 
demonstrated by late changes on funduscopy, areas of delayed retinal degeneration on 
histology and delayed loss of the b wave function on ERG in comparison to other 
breeds.(17,19) There is a relatively high prevalence of prcd mutations in this breed, which is 
a late onset form of PRA.(16,21) In the present study, all of the dogs included were ECS 
which is a very popular breed in the United Kingdom and one of the most common dog 
breeds presented to the RVC during the period of the study. When counselling the owners, it 
was discussed, that the visual outcome and how long the dog could remain visual post-
surgery, were unknown at the time. The decision to operate one or both eyes was based on 
the clinician’s recommendation and the owner’s decision. 
In this study, six eyes regained and maintained vision after surgery for over three years. The 
improvement of vision was significant until P5, which was the time period between 1.5 and 2 
years post-surgery. (See figure 1, figure 2) Considering that dogs affected by PRA were not 
routinely operated in the past, the authors were encouraged that many dogs in this study 
benefitted from vision improvement for such a long time.  
Several eyes with an initial flat trace did regain vision after surgery, as reported in the results, 
which was found significant from P1 to P4. However, these findings raise questions about the 
accuracy of the different ERG readings and subjectivity of the menace response for vision 
testing. The ERG readings were likely affected by positioning, state of consciousness, type of 
anaesthesia, severity of the cataracts and noise, making it challenging to distinguish between 
a reduced b-wave amplitude and a flat line. (22-24) This is considered a limitation of this 
study, as it was performed retrospectively and at different centres with various ERG 
protocols and ERG machines and various states of consciousness, which need to be 
considered when comparing ERG results with each other as it may have affected the 
results.(24) In order to assess the validity of the ERG result in eyes with reduced 
photoreceptor function, the ERG protocols require standardisation in several aspects. Ideally, 
the same ERG machines and the same protocol should have been used. The recommended 
protocols for diagnosis of photoreceptor disorders imply that all ERGs include twenty 
minutes dark adaption, testing of a mixed rod cone response, testing of cone function after ten 
minutes of light adaption and a flicker test. (25,26) These protocols, together with a 
standardized approach to perform the ERG either sedated or anaesthetized, in the same room 
and with the same ERG machine, would improve the validity of the ERG results, to allow a 
more accurate investigation into the presence of a photoreceptor disorder. This was a clinical 
study. A suspicion of PRA was made based on the history, signalment, full ophthalmic 
examination before or after surgery and, in the majority of cases, supported by the ERG 
results. In this study, the suspicion of PRA was further supported in one case by genetic 
testing. The cases without an ERG were included following careful selection based on their 
history, signalment, full ophthalmic examination, the presence of attenuated retinal 
vascularization and tapetal hyper-reflectivity on funduscopy and if nyctalopia was reported. 
The ERGs were performed to add weight to the suspicion of PRA. Repeating ERGs at later 
stages as well as using the standardized protocol for diagnosis of photoreceptor disorders, 
could have further supported the diagnosis of PRA and aided in the assessment of the 
progression of vision loss. However, this would have meant, that the patient would require 
several anaesthesias or sedations, which is not feasible in a clinical setting, it may elicit 
phototoxic effects on the diseased retina and, in the authors opinion, would not have been in 
the best interest of the patient.  
Many clients mentioned that the photopic vision had returned, however these observations 
were not reported routinely for every case and therefore these results were not used to report 
the visual outcome post-surgery. For consistency, the visual outcome was reported based on 
the presence or absence of menace responses in clinical examinations. However, the menace 
response is only a crude test for vision and cannot provide detailed information about the 
degree of photoreceptor degeneration. Furthermore, it would be interesting to analyse the 
effect of the phototoxic effect of the operating microscope light on retinas with PRA as well 
as safe exposure time. The use of an ultraviolet radiation filter or a yellow filter could be 
considered to reduce phototoxicity in patients with PRA, however there is no strong evidence 
in the literature that this measure would decrease photoreceptor destruction during surgery in 
cases with PRA. (27,28)  
 
There was no statistical effect of the referral centre, age, gender, abnormality on gonioscopy 
or ocular ultrasound, cataract stage, dazzle reflex, vision before surgery or IOL placement on 
the visual outcome post-surgery as assessed by GEE. The association of funduscopic findings 
with visual outcome could not be evaluated statistically. The detailed description of findings 
on fundoscopy varied between clinicians and therefore, funduscopic findings were described 
only. For the same reasons, it was not possible to establish a standardized approach to assess 
the progression of the degree of funduscopic changes and their association with the visual 
outcome in this retrospective study, however this would be an interesting question for future 
studies. The use of diagnostic imaging like fundus photography or OCT could be considered 
for standardisation of the findings and to assess for progression of the degree of retinal 
atrophy. 
In this study, owners were contacted and asked about the perceived quality of life of their dog 
after surgery. The response rate to the questionnaire was 48.2 %. This lies just below the 
mean response rate for academic studies, which could be explained by the long study period 
and that some dogs were already deceased at the time of the questionnaire.(29) We cannot 
base conclusions out of this low response rate. However, we would like to report that, of all 
responses, 92.5 % owners replied that the quality of life of their dog had improved 
significantly after surgery.  
 
There are further limitations to this study, due to its retrospective nature, which may have 
influenced the results. There was loss to follow up, which increased with each re-examination 
time period and as demonstrated in the tables. Due to the descriptive nature of this study, we 
decided to still report all long-term results, even though this holds a small potential for 
overreaching conclusions. Furthermore, we described the PRA diagnosis as ‘suspected’, as 
most cases were diagnosed by history, signalment, clinical examination and short ERG, but 
were not confirmed by the recommended protocol for diagnosis of photoreceptor disorders, 
multiple ERGs, or gene tests in the majority of cases. To address this, we only included cases 
with a sufficient follow up and repeatedly confirmed suspicion/diagnosis by diplomates or 
residents under supervision of diplomates of the ECVO.  
Finally, the quality of life questionnaire answered by clients was subjective and further 
studies to validate a quality of life tool for this purpose are required.  
 
Conclusion: 
Phacoemulsification in ECS with suspected PRA and secondary cataract development can be 
recommended. Visual improvement can be obtained for some time, but as expected the day 
vision will be lost eventually. No predictor for a successful visual outcome following surgery 
could be identified. However, vision was present for up to two years in this study population 
and this was significant when comparing to vision before surgery. ERGs were useful in 
supporting the suspicion of PRA but no conclusion on visual outcome associated with ERG 
results could be drawn, as the ERGs were not standardized. The response rate of the 
questionnaire was low; however, most participants reported an improved quality of life of 
their dogs.  
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Table 1. Summary of ERG protocols used at the RVC, AHT and DWR 





RVC 1 Anaesthetized No dark 
adaption 
1) 3000 mcd.s/m^2, 1 flash each 0s 
5 dogs     2) 3000 mcd.s/m^2, 1 flash each 0s 
    Light off 3) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
      4) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
    Five minute 
dark adaption 
5) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
      6) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
      7) 10000 mcd.s/m^2, 4 flashes, 1 each 20s 
      8) 10000 mcd.s/m^2, 4 flashes, 1 each 20s 
      9) Flicker 3000 mcd.s/m^2, 128 flashes, 1 
each 0.033s 
      10) Flicker 3000 mcd.s/m^2, 128 flashes,1 
each 0.033s 
RVC 2 Anaesthetized One minute 
dark adaption 
1) 0 mcd.s/m^2, 4 flashes, 1 each 1s,  
9 dogs     2) 0 mcd.s/m^2, 4 flashes,1 each 1s 
      3) 10 mcd.s/m^2, 10 flashes,1 each 2s 
      4) 10 mcd.s/m^2, 10 flashes, 1 each 2s 
      5) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
      6) 3000 mcd.s/m^2, 4 flashes, 1 each 10s 
      7) 10000 mcd.s/m^2, 4 flashes, 1 each 20s 
      8) 10000 mcd.s/m^2, 4 flashes,1 each 20s 
      9) Flicker 3000 mcd.s/m^2, 128 flashes, 1 
each 0.033s 
      10) Flicker 3000 mcd.s/m^2, 128 flashes, 
1 each 0.033s 
AHT  Conscious One minute 
dark adapted 
64 lx.s at a distance of 30 cm, 10 flashes 
(averaged), manually elicited, flash 
duration of 10 ms 
30 dogs     Intensitiy control: 7 steps linear control. 
Used: Step 7 
DWR Conscious Not dark 
adapted 
9000 mcd, 10 flashes (averaged) each 400 
ms (2.59Hz) 
2 dogs       
Legend: mcd.s/m^2 = millicandelas.second/square metre, s = second, ms = millisecond, Hz = 
Herz  
  
Table 2. Summary of visual outcome per eye before and after surgery and significance of 
visual improvement compared to before surgery 
 
  All eyes           McNemar 






surgery 85 19 22.4 66 77.6   
  
P1* 85 75 88.2 10 11.8   0.000 
P2* 63 58 92.1 5 7.9 22 0.000 
P3* 46 44 96.7 2 4.3 39 0.000 
P4* 32 31 96.9 1 3.1 53 0.000 
P5* 19 16 84.2 3 15.8 66 0.003 
P6 15 9 60.0 6 40.0 70 0.289 
P7 10 6 60.0 4 40.0 75 0.453 
P = time period, p = significance level 
 
Table 3. Summary of visual outcome following surgery, of eyes that had a flat ERG trace 
before surgery and significance of visual improvement compared to before surgery 
  Flat ERG 
before 
surgery  
          McNemar 






surgery 30 5 16.7 25 83.3   
  
P1* 30 22 73.3 8 26.7   0.000 
P2* 21 17 81.0 4 19.0 9 0.000 
P3* 10 8 80.0 2 6.7 20 0.031 
P4* 8 7 87.5 1 12.5 22 0.031 
P5 5 4 80.0 1 3.3 25 0.250 
P6 4 2 50.0 2 50.0 26 1.000 
P7 3 2 66.7 1 33.3 27 1.000 
P = time period, p = significance level 
  
Figure 1. Summary of visual and blind eyes before and after surgery. Missing eyes were lost 
to follow up. Significant improvement of visual outcome was marked with * 
 
  
Figure 2. Operated vs not operated eyes. One box represents the visual outcome of one eye 
per exam period. Development of an eye can be followed from left to right. Black boxes 
stand for blind eyes, grey boxes for visual eyes, white boxes stand for loss to follow up or 
menace response not specified
 
Figure 3. Summary of visual outcome of eyes that had a flat ERG trace before surgery. 
Significant improvement of visual outcome was marked with * 
 
  
Figure 4. Summary of complications diagnosed at re‐examinations at all time periods post‐
surgery 
 
